Calcium- and integrin-binding protein-1 and calcineurin are upregulated in the right atrial myocardium of patients with atrial fibrillation

Europace

Volumn 14, Issue 12, 2012, Pages 1726-1733

  Zhao, Fei ^a   Zhang, Shijiang ^a   Chen, Liang ^a   Wu, Yanhu ^a   Qin, Jianwei ^a   Shao, Yongfeng ^a   Wang, Xiaowei ^a   Chen, Yijiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Atrial remodel; Calcineurin; CIB1; Human myocardium

Indexed keywords

CALCINEURIN; CALCINEURIN A; CALCINEURIN B; CALCIUM; CALCIUM AND INTEGRIN BINDING PROTEIN 1; INTEGRIN; NCX1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARDIAC PATIENT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HEART VALVE REPLACEMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; UPREGULATION; VALVULAR HEART DISEASE;

ADOLESCENT; ATRIAL FIBRILLATION; CALCINEURIN; CALCIUM-BINDING PROTEINS; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 84870228714     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus149     Document Type: Article

References (20)

1. Ross J Jr. Left ventricular function and the timing of surgical treatment in valvular heart disease. Ann Intern Med 1981;94:498-504. (Pubitemid 11103957)
2. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141-51. (Pubitemid 43795057)
3. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. (Pubitemid 35417773)
4. Everett THt, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007;4:S24-7.
5. Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 2008;65:1489-508.
6. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79. (Pubitemid 34327915)
7. Duytschaever M, Blaauw Y, Allessie M. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs. Cardiovasc Res 2005;67:69-76. (Pubitemid 40803460)
8. Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ et al. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Heart Rhythm 2005;2:223-30. (Pubitemid 40309815)
9. Bukowska A, Lendeckel U, Hirte D, Wolke C, Striggow F, Rohnert P et al. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. Cell Mol Life Sci 2006;63:333-42. (Pubitemid 43202314)
10. Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 2008; 103:845-54.
11. Heineke J, Auger-Messier M, Correll RN, Xu J, Benard MJ, Yuan W et al. CIB1 is a regulator of pathological cardiac hypertrophy. Nat Med 2010;16:872-9.
12. Burashnikov A, Antzelevitch C. Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacol Ther 2011;132:300-13.
13. Neef S, Dybkova N, Sossalla S, Ort KR, Fluschnik N, Neumann K et al. CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 2010;106:1134-44.
14. Tandan S, Wang Y, Wang TT, Jiang N, Hall DD, Hell JW et al. Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ Res 2009;105:51-60.
15. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR et al. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 2004;279:26192-200. (Pubitemid 38798765)
16. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-28. (Pubitemid 28180855)
17. Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A et al. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol 2009;104: 435-48.
18. Dobrev D. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol 2010;381:195-206.
19. Luo CH, Rudy Y. A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation. Circ Res 1994;74: 1097-113. (Pubitemid 24176904)
20. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88:1159-67. (Pubitemid 34132516)